A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

A.Y. Finlay, Ghazala Khan · Clinical and Experimental Dermatology · 1994 · 5.4K citations

Quality Of Life, Life Assessment, Allergy +12

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

Severe Psoriasis – Oral Therapy with a New Retinoid

T Fredriksson, U. Pettersson · Dermatology · 1978 · 2.7K citations

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.3K citations

Inflammation, Rheumatology, Rheumatoid Disorder +14

Psoriasis causes as much disability as other major medical diseases

Stephen R. Rapp, Steven R. Feldman, M. Lyn Exum et al. · Journal of the American Academy of Dermatology · 1999 · 1.5K citations

Autoimmune Disease, Disease Mechanism, Medicine +4